GB8730190D0 - New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters - Google Patents

New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters

Info

Publication number
GB8730190D0
GB8730190D0 GB878730190A GB8730190A GB8730190D0 GB 8730190 D0 GB8730190 D0 GB 8730190D0 GB 878730190 A GB878730190 A GB 878730190A GB 8730190 A GB8730190 A GB 8730190A GB 8730190 D0 GB8730190 D0 GB 8730190D0
Authority
GB
United Kingdom
Prior art keywords
comt
catechol
inhibitors
esters
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB878730190A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Priority to GB878730190A priority Critical patent/GB8730190D0/en
Publication of GB8730190D0 publication Critical patent/GB8730190D0/en
Priority to GB888820729A priority patent/GB8820729D0/en
Priority to ZA889256A priority patent/ZA889256B/en
Priority to KR1019880016718A priority patent/KR890009384A/en
Priority to MT1031A priority patent/MTP1031B/en
Priority to IL8873488A priority patent/IL88734A/en
Priority to DK713288A priority patent/DK713288A/en
Priority to SE8804608A priority patent/SE8804608L/en
Priority to IE883816A priority patent/IE883816L/en
Priority to DE3843324A priority patent/DE3843324A1/en
Priority to CH4750/88A priority patent/CH683395A5/en
Priority to LU87412A priority patent/LU87412A1/en
Priority to EP88312228A priority patent/EP0323162B1/en
Priority to ES88312228T priority patent/ES2059546T3/en
Priority to PH37972A priority patent/PH27037A/en
Priority to US07/288,979 priority patent/US5001152A/en
Priority to HU886594A priority patent/HU200684B/en
Priority to IT8823107A priority patent/IT1227914B/en
Priority to JP63327515A priority patent/JPH02196715A/en
Priority to AU27459/88A priority patent/AU617397B2/en
Priority to BE8801433A priority patent/BE1003759A5/en
Priority to UA4894881A priority patent/UA15922A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
GB878730190A 1987-12-24 1987-12-24 New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters Pending GB8730190D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GB878730190A GB8730190D0 (en) 1987-12-24 1987-12-24 New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters
GB888820729A GB8820729D0 (en) 1987-12-24 1988-09-01 Substituted beta-diketones
ZA889256A ZA889256B (en) 1987-12-24 1988-12-09 New use of catechol-o-methyl transterase(comt)inhibitors and their physiologically acceptable salts and esters
KR1019880016718A KR890009384A (en) 1987-12-24 1988-12-15 Novel use of catechol-0-methyltransferase (COMT) inhibitors and their physiologically available salts and esters
MT1031A MTP1031B (en) 1987-12-24 1988-12-16 New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
IL8873488A IL88734A (en) 1987-12-24 1988-12-20 Pharmaceutical compositions comprising a comt inhibitor
DK713288A DK713288A (en) 1987-12-24 1988-12-21 USE OF CATACOL-O-METHYL TRANSPHERASE INHIBITORS AND PHYSIOLOGICALLY ACCEPTABLE SALTS AND ESTERS THEREOF
SE8804608A SE8804608L (en) 1987-12-24 1988-12-21 NEW USE OF CATECOL-O-METHYL TRANSFERRED (COMT) INHIBITORS AND THEIR PHYSIALLY ACCEPTABLE SALTS AND ESTERS
IE883816A IE883816L (en) 1987-12-24 1988-12-21 New use of catechol-o-methyl transferase (COMT) inhibitors and their physiologically acceptable salts and esters
PH37972A PH27037A (en) 1987-12-24 1988-12-22 Use of catechol-o-methyl transferase (COMT) inhibitors and their physiologically acceptance salts and esters for ulcer treatments
CH4750/88A CH683395A5 (en) 1987-12-24 1988-12-22 Use of catechol-O-methyl-transferase inhibitors and salts thereof and physiologically acceptable esters.
DE3843324A DE3843324A1 (en) 1987-12-24 1988-12-22 NEW USE OF CENTRAL-0-METHYL TRANSFERASE (COMT) INHIBITORS AND THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS AND ESTERS
LU87412A LU87412A1 (en) 1987-12-24 1988-12-22 NOVEL USE OF CATECHOL-0-METHYL TRANSFERASE (COMT) INHIBITORS AND THEIR PHYSIOLOGICALLY ACCEPTABLE ESTERS AND SALTS
EP88312228A EP0323162B1 (en) 1987-12-24 1988-12-22 New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
ES88312228T ES2059546T3 (en) 1987-12-24 1988-12-22 USE OF A CATECOL-O-METHYL-TRANSFERASE (COMT) INHIBITOR ONE OF ITS PHYSIOLOGICALLY ACCEPTABLE SALTS OR ESTERS.
BE8801433A BE1003759A5 (en) 1987-12-24 1988-12-23 NEW USE OF INHIBITORS CATECHOL-0-Methyl TRANSFERASE (COMT) ESTERS AND THEIR SALTS AND ACCEPTABLE PHYSIOLOGICALLY.
HU886594A HU200684B (en) 1987-12-24 1988-12-23 Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and active on gastrointestinal tract
US07/288,979 US5001152A (en) 1987-12-24 1988-12-23 Use of catechol-O-methyl transferase (COMT) inhibitors and their physiologically acceptable salts for ulcer treatment
IT8823107A IT1227914B (en) 1987-12-24 1988-12-23 NEW USE OF CATHYL-O-METHYLTRANSPHERASE INHIBITORS AND THEIR PHYSIOLOGICALLY ACCEPTED SALTS AND ESTERS
JP63327515A JPH02196715A (en) 1987-12-24 1988-12-23 Therapy or preventive for gastrointestinal tract ulcer, lesion or the like, containing catechol derivative as effective ingredient
AU27459/88A AU617397B2 (en) 1987-12-24 1988-12-23 New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
UA4894881A UA15922A1 (en) 1987-12-24 1989-09-01 METHOD OF OBTAINING SUBSTITUTE BETA DICKETS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878730190A GB8730190D0 (en) 1987-12-24 1987-12-24 New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters

Publications (1)

Publication Number Publication Date
GB8730190D0 true GB8730190D0 (en) 1988-02-03

Family

ID=10629088

Family Applications (2)

Application Number Title Priority Date Filing Date
GB878730190A Pending GB8730190D0 (en) 1987-12-24 1987-12-24 New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters
GB888820729A Pending GB8820729D0 (en) 1987-12-24 1988-09-01 Substituted beta-diketones

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB888820729A Pending GB8820729D0 (en) 1987-12-24 1988-09-01 Substituted beta-diketones

Country Status (4)

Country Link
KR (1) KR890009384A (en)
GB (2) GB8730190D0 (en)
UA (1) UA15922A1 (en)
ZA (1) ZA889256B (en)

Also Published As

Publication number Publication date
GB8820729D0 (en) 1988-10-05
KR890009384A (en) 1989-08-01
UA15922A1 (en) 1997-06-30
ZA889256B (en) 1989-08-30

Similar Documents

Publication Publication Date Title
GR3020843T3 (en) Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
EP0295721A3 (en) Promotion of healing of meniscal tissue
ZA889111B (en) Surfactant inhibition of dental plaque
IL92545A0 (en) Preparation of 2-chloropyridine-3-carboxylic acid esters
ZA885370B (en) Dna clone of human tissue factor inhibitor
ZA891402B (en) 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion
DE3263917D1 (en) Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof
EP0323162A3 (en) New use of catechol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
AR245125A1 (en) Procedure for the preparation of arylpiperazinyl-alkylenphenyl-p-heterocyclic compounds and their pharmaceutically acceptable salts from acid addition.
ZA883744B (en) Promotion of healing of meniscal tissue
EP0237796A3 (en) New use of prostaglandin biosynthesis inhibitors
PH25869A (en) Catechol carboxylic acid derivatives and compositions thereof
GB8730190D0 (en) New use of catechol-o-methyl transferase(comt)inhibitors & their physiologically acceptable salts & esters
IL95484A0 (en) Iodopropargyl esters of alpha-amino acid derivatives and their use as antimicrobial agents
IL93590A0 (en) Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them
IL88037A0 (en) Potentiation of antihypertensive effect of ace inhibitors
IL89287A (en) Halogenated phosphonic acid derivatives and aspartate transcarbamylase inhibitors and compositions containing them for tumor therapy
GR870889B (en) Preparation mehtod of new 4- phenyl 4-oxo 2- butenic acid derivatives
IL86930A0 (en) Preparation of piperidinylcyclopentylheptenoic acid derivatives
NZ229605A (en) Preparation of 1,4-dihydro-6-fluoro-7-(piperazin-1-yl)-4-oxo-3-quinoline (or naphthyridine) carboxylic acid derivatives
IL88310A0 (en) Treatment of factor viii inhibitors
ZA921381B (en) New use of amino acid derivatives
GB8717997D0 (en) Derivatives of benzoyloxyacetic acid
ZA913511B (en) New pharmaceutical use of benzocycloheptathiophene carboxylic acid derivatives
IE871327L (en) Inhibitor of c5a - mediated chemotaxin